Antagonism of CD11b with Neutrophil Inhibitory Factor (NIF) Inhibits Vascular Lesions in Diabetic Retinopathy

Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury

(2013) Mohd Hafeez Faridi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

(2012) Jie Ding et al.   Current Diabetes Reports

Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice

(2012) G. Li et al.   DIABETES

Importance of the NHANES 2005-2008 Diabetic Retinopathy Data

(2011) Robert N. Frank   ARCHIVES OF OPHTHALMOLOGY

Opening the Field of Integrin Biology to “Biased Agonism”

(2011) Daniel I. Simon   CIRCULATION RESEARCH

Infections associated with monoclonal antibody and fusion protein therapy in humans

(2011) Florence Uettwiller et al.   mAbs

Prevalence of Diabetic Retinopathy in the United States, 2005-2008

(2010) Xinzhi Zhang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pyk2 Is Required for Neutrophil Degranulation and Host Defense Responses to Bacterial Infection

(2010) L. A. Kamen et al.   JOURNAL OF IMMUNOLOGY

Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies

(2009) Eugene O. Major   Annual Review of Medicine

Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection

(2009) J. A. Van Ziffle et al.   BLOOD